Susquehanna International Group, LLP Uro Gen Pharma Ltd. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$12.7 - $17.92 $163,830 - $231,168	-12,900 Reduced 22.43%	44,600 $566,000
Q2 2024 Aug 15, 2024	BUY	$12.72 - $19.2 $389,232 - $587,520	30,600 Added 113.75%	57,500 $964,000
Q1 2024 May 07, 2024	BUY	$13.81 - $19.33 $371,489 - $519,976	26,900 New	26,900 $403,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $45,968 - $117,728	5,200 Added 39.1%	18,500 $259,000
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $116,375 - $190,057	13,300 New	13,300 $137,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $254M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.